Bionano Genomics Inc (BNGO)

[vuala]

gracias, se agradece mucho, Laua   

[lauramsagra]

https://newsfilter.io/articles/bionano-genomics-to-report-first-quarter-2020-financial-results-and-host-a-conference-call-and-webca-914b5573feb2999b0a319911621faf04

[CSEBAS]

 

[lauramsagra]

Bionano Genomics, Inc. (BNGO)
NasdaqCM - NasdaqCM Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
0,555+0,0475 (+9,3596 %)

[lauramsagra]

Menuda vela de 15 minutos....10 millones de acciones, algo se cuece, o cortos saliendo a saco o largos y los cortos huiran antes o despues. Me extrañaria que despues de este volumen no haya buenas noticias luego


copio y pego

[Fidodido]

Resultados desastrosos, como no vendan bien la moto en la call y posteriormente... mañana a vigilar la pérdida del 0,47$, si los pierde, directa a los 0,44$ y sería pérdida de la mini tendencia alcista que llevaba. Mañana crucial la reacción, pero pintan bastos bastos. 

[vuala]

bueno, aquí son más optimistas

https://www.markets.co/bionano-genomics-bngo-receives-a-buy-from-oppenheimer/259359/

BIONANO GENOMICS (BNGO) RECEIVES A BUY FROM OPPENHEIMER
June 18, 2020 Catie Powers Healthcare Leave a comment

In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on BioNano Genomics (BNGO – Research Report), with a price target of $1.50. The company’s shares closed last Thursday at $0.52, close to its 52-week low of $0.25.

According to TipRanks.com, DeGeeter is a 5-star analyst with an average return of 24.8% and a 52.8% success rate. DeGeeter covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, Rocket Pharmaceuticals, and Ionis Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BioNano Genomics with a $1.83 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $4.70 and a one-year low of $0.25. Currently, BioNano Genomics has an average volume of 7.77M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

[OCIN]

en premercado...

0.495   -0.0256   (-4.92%)
Before Hours Volume: 26.5K

[Fidodido]

bueno, aquí son más optimistas

https://www.markets.co/bionano-genomics-bngo-receives-a-buy-from-oppenheimer/259359/

BIONANO GENOMICS (BNGO) RECEIVES A BUY FROM OPPENHEIMER
June 18, 2020 Catie Powers Healthcare Leave a comment

In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on BioNano Genomics (BNGO – Research Report), with a price target of $1.50. The company’s shares closed last Thursday at $0.52, close to its 52-week low of $0.25.

According to TipRanks.com, DeGeeter is a 5-star analyst with an average return of 24.8% and a 52.8% success rate. DeGeeter covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, Rocket Pharmaceuticals, and Ionis Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BioNano Genomics with a $1.83 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $4.70 and a one-year low of $0.25. Currently, BioNano Genomics has an average volume of 7.77M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Disculpa Vuala, esta info es del 18/06, pero es previa a la presentación de resultados o posterior?

[vuala]

no lo sé  :-(

[Fidodido]

Puse orden en 0,47$ para entrada con paquete que utilizaré especulativamente y me entró. Ya os dije que era muy importante aguantarlos y parece que lo hará. Aun los resultados se está comportando muy muy bien. Y dejármelo decir, vaya chicharrazo!!! 

[CSEBAS]

 

Haces bien. Creo que le queda poco para despegar.
Hoy se ha quitado a los que tienen prisa. 

 

[vuala]

al final el cierre no es tan bueno como hubiera querido, cerca de 0,50$ pero podria haber sido peor 

[Fidodido]

Puse orden en 0,47$ para entrada con paquete que utilizaré especulativamente y me entró. Ya os dije que era muy importante aguantarlos y parece que lo hará. Aun los resultados se está comportando muy muy bien. Y dejármelo decir, vaya chicharrazo!!! 

Pues funcionando bien, consolidando y hoy otra buena noticia haciéndola subir en Pre market, cualquier día nos da una alegría de las buenas, os cuelgo noticia que está haciéndola sublr hoy 👇🏻

https://m.benzinga.com/article/16382160?utm_referrer=https%3A%2F%2Fwww.benzinga.com%2Fgeneral%2Fbiotech%2F20%2F06%2F16404457%2Fbionano-genomics-announceskings-college-hospital-london-medical-college-of-wisconsin-and-yonsei-u&utm_source=https%3A%2F%2Fwww.benzinga.com%2Fgeneral%2Fbiotech%2F20%2F06%2F16404457%2Fbionano-genomics-announceskings-college-hospital-london-medical-college-of-wisconsin-and-yonsei-u

[CSEBAS]